To save more lives through the discovery and development of therapies that mobilize the immune system to attack all types of cancer.
The Cancer Research Institute (CRI), established in 1953, is the world's only nonprofit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts to develop new and effective immune system-based strategies to prevent, diagnose, treat, and eventually cure all cancers.
Guided by a world-renowned Scientific Advisory Council that includes three Nobel laureates and 27 members of the National Academy of Sciences, CRI has invested $311 million in support of research conducted by immunologists and tumor immunologists at the world's leading medical centers and universities, and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of cancer treatment.
CRI is committed to educating patients, caregivers, and health care professionals about the latest advances in cancer immunotherapy, and connects patients to clinical trials of cutting-edge treatments.
Where We Work
What We Do
Cancer Research Institute provides research grants along all stages of medical research, from the laboratory to the clinic, through its highly competitive Postdoctoral Fellowship Program, Clinic and Laboratory Integration Program, and Clinical Accelerator initiatives. To date, CRI has funded more than 3,000 scientists, whose work has led to lifesaving immunotherapies in a variety of cancers. With continued research, immunotherapy will one day soon have broad impact across all types of cancer.